NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF), the leading nonprofit that funds food allergy research, has marked a significant milestone in the field: a first-ever Food Allergy Research Roadmap. This roadmap is designed to accelerate medical discovery and development progress within the next five years, and it's the most comprehensive tool the food allergy community has ever had. FAF brought together an exclusive working group of renowned scientists and allergists to identify the root causes of food allergies and focus on cutting-edge approaches to prevent, treat, and cure the disease.
"The food allergy community has never had a real-time tool like this roadmap, and it is an essential next step in hastening our progress to find a cure for the disease," said Ilana Golant, founder and CEO of the Food Allergy Fund. "To end food allergies, we have assembled the brightest minds in America to help us map our goals, pool resources, and collaborate across disciplines, proactively changing the research culture."
While current food allergy research primarily targets disease symptoms and single-food immunotherapy treatments, FAF's Research Roadmap adopts a transformative approach. It prioritizes prevention and cures for multiple food allergies and allergic diseases, developing disease-modifying therapeutics and catalyzing multiple proof-of-concept clinical trials. The FAF Research Roadmap will serve as a scientific business plan for scientists and funders.
Over the next five years, FAF will focus on eliminating anaphylactic reactions, inducing and maintaining immune tolerance to foods, and preventing food allergy in the next child or adult. FAF's vision includes:
- Forging partnerships between academia and industry
- Utilizing AI-driven platforms
- Recruiting new talent and medical disciplines
- Hosting curated research retreats
- Repurposing therapeutics
- Creating a venture philanthropy platform to address the funding gap
Food allergies are a pressing public health crisis. The CDC’s National Center for Health Statistics revealed that nearly one-third of U.S. adults and over one-fourth of U.S. children reported experiencing seasonal allergies, eczema, or food allergies. Additionally, approximately six percent of both U.S. adults and children have food allergies.
Watch the launch presentation at the Food Allergy Fund’s marquee event, a gathering of leading scientists, CEOs, entrepreneurs, and advocates in New York to learn more from the Research Roadmap Working Group.
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF's grants support the creation of new treatments that will address the root causes of food allergies. Through our groundbreaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
